Baird Medical Investment Holdings (BDMD) Payables (2023 - 2026)

Baird Medical Investment Holdings (BDMD) has reported Payables for 4 consecutive years, with $3.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables fell 77.99% year-over-year to $3.5 million in Q2 2026; TTM through Jun 2026 was $3.5 million, a 77.99% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 61.57% from the prior year.
• Payables was $3.5 million for Q2 2026 at Baird Medical Investment Holdings, down from $6.7 million in the prior quarter.
• Over five years, Payables peaked at $17.4 million in Q4 2024 and troughed at $3.5 million in Q2 2026.
• A 4-year average of $10.5 million and a median of $8.7 million in 2023 frame the typical range for Payables.
• Across the five-year window, Payables surged 99.83% in 2024 and plunged 77.99% in 2026, its largest moves.
• Over 4 years, Payables stood at $8.7 million in 2023, then soared by 99.83% to $17.4 million in 2024, then sank by 61.57% to $6.7 million in 2025, then tumbled by 47.1% to $3.5 million in 2026.
• The last three Payables figures came in at $3.5 million (Q2 2026), $6.7 million (Q4 2025), and $16.1 million (Q2 2025), per Business Quant data.